NCT05887960

Impact of Neutrophil Lymphocyte and Monocyte Lymphocyte Ratio on Chronic Kidney Disease Patients Outcome

Name: Clinical Trial NCT05887960
Creator: Assiut University
Keywords: Hemodialysis Complication, CBC and flow cytometry test for monocyte, other, clinical trial

Assiut University·ClinicalTrials.gov·otherNot yet recruiting

View on ClinicalTrials.gov →

Study focus

Disease/Condition: Hemodialysis Complication
Drug/Device/Intervention: CBC and flow cytometry test for monocyte
Study type: Observational
Intervention type: other

Sponsor & location

Primary sponsor: Assiut University

Timeline & enrollment

Phase: N/A
Start date: Jun 01, 2023
End date: Oct 01, 2024
Enrollment: 200 participants

Primary outcome

Impact of neutrophil lymphocyte and monocyte lymphocyte ratio on chronic kidney disease patients outcome

Summary

The aim of this study is to establish NLR, MLR as a good predictors for outcome of CKD including hemodialysis and CKD stage (4-5) patients as regard inflammation, malnutrition and anemia on cardiovascular complication.

ICD-10 classifications

Kidney dialysisOther dialysisCare involving dialysisMechanical complication of vascular dialysis catheterHaemoglobinuria due to haemolysis from other external causes

Data source

Registry: ClinicalTrials.gov
Trial ID: NCT05887960
Type: Non-Device Trial

About this record

Access comprehensive clinical trial information for NCT05887960 through Pure Global AI's free database. This phase not specified trial is sponsored by Assiut University and is currently Not yet recruiting. The study focuses on Hemodialysis Complication. Target enrollment is 200 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.